CWM
TTNP

Cornerstone Wealth Management’s Titan Pharmaceuticals TTNP Stock Holding History

Cornerstone Wealth Management’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-58
Closed -$6K – 434
2020
Q3 		$6K Hold
58
– – ﹤0.01% 387
2020
Q2 		$11K Hold
58
– – ﹤0.01% 375
2020
Q1 		$8K Buy
58
+25
+76% +$3.91K ﹤0.01% 345
2019
Q4 		$4K Buy
+33
New +$3.98K ﹤0.01% 349
2018
Q4 		– Sell
-1
Closed -$1M – 1090
2018
Q3 		$1M Buy
+1
New +$2.72K 0.01% 704
2018
Q2 		– Hold
0
– – – 773

Other funds holding TTNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TI
tru Independence Portland, Oregon $202M AUM 15.81% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Cornerstone Wealth Management's TTNP Position: Q4 2020 in Review

Cornerstone Wealth Management sold out of Titan Pharmaceuticals (TTNP) in Q4 2020, closing a stake of 58 shares — an estimated $6K sold.

Cornerstone Wealth Management first reported a position in TTNP in Q3 2018 and held it in 5 quarters. The position peaked at $1M in Q3 2018. 15 funds tracked by Wall St. Rank hold TTNP as of Q4 2020.

  • Cornerstone Wealth Management reported no remaining Titan Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Cornerstone Wealth Management sold 58 Titan Pharmaceuticals shares in Q4 2020, an estimated $6K.
  • Cornerstone Wealth Management first reported a position in Titan Pharmaceuticals in Q3 2018 and held it in 5 quarters.
  • Cornerstone Wealth Management's Titan Pharmaceuticals position peaked at $1M in Q3 2018.
  • 15 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2020.

Based on Cornerstone Wealth Management's 13F filing for Q4 2020, filed 29 Jan 2021.